Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |